Evidence map›Paper›PMID 21261288›Full record

ArticleBiochemistry2011

Evidence for a high-spin Fe(IV) species in the catalytic cycle of a bacterial phenylalanine hydroxylase.

Aram Joel Panay, Michael Lee, Carsten Krebs, J Martin Bollinger, Paul F Fitzpatrick

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 83 citations in OpenAlex.

  1. Review
  2. Nonheme FeInorganic chemistry · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Mechanisms of OBiochemistry · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. The oxidation of cyclo-olefin by the S = 2 ground-state complex [FeJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  11. Structure of full-length human phenylalanine hydroxylase in complex with tetrahydrobiopterin.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  12. Review
  13. Dioxygen activation by nonheme iron enzymes with the 2-His-1-carboxylate facial triad that generate high-valent oxoiron oxidants.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2017
    Review
  14. OBiochemistry · 2016
    Article
  15. Article
  16. Review
  17. Mono- and binuclear non-heme iron chemistry from a theoretical perspective.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2016
    Review
  18. Article
  19. Review
  20. What factors influence the reactivity of C-H hydroxylation and C=C epoxidation by [Fe(IV)(L(ax))(1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane)(O)](n+).Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Aram Joel PanayDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States.
Michael Lee
Carsten Krebs
J Martin Bollinger
Paul F Fitzpatrick
Pennsylvania State University · USTexas A&M University · USThe University of Texas Health Science Center at San Antonio · US

Funding

NEUROTRANSMITTER BIOSYNTHESISR01GM047291 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI FITZPATRICK, PAUL F. · 1992 to 2011
$3.2M
Mechanism of Taurine: Alpha-Ketoglutarate DioxygenaseR01GM069657 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI BOLLINGER, JOSEPH M, KREBS, CARSTEN · 2004 to 2016
$2.7M
NIGMS NIH HHS R01 GM047291NIGMS NIH HHS R01 GM069657NIGMS NIH HHS R01 GM 69657
6 · The paper itself

Abstract

Phenylalanine hydroxylase is a mononuclear non-heme iron protein that uses tetrahydropterin as the source of the two electrons needed to activate dioxygen for the hydroxylation of phenylalanine to tyrosine. Rapid-quench methods have been used to analyze the mechanism of a bacterial phenylalanine hydroxylase from Chromobacterium violaceum. Mössbauer spectra of samples prepared by freeze-quenching the reaction of the enzyme-(57)Fe(II)-phenylalanine-6-methyltetrahydropterin complex with O(2) reveal the accumulation of an intermediate at short reaction times (20-100 ms). The Mössbauer parameters of the intermediate (δ = 0.28 mm/s, and |ΔE(Q)| = 1.26 mm/s) suggest that it is a high-spin Fe(IV) complex similar to those that have previously been detected in the reactions of other mononuclear Fe(II) hydroxylases, including a tetrahydropterin-dependent tyrosine hydroxylase. Analysis of the tyrosine content of acid-quenched samples from similar reactions establishes that the Fe(IV) intermediate is kinetically competent to be the hydroxylating intermediate. Similar chemical-quench analysis of a reaction allowed to proceed for several turnovers shows a burst of tyrosine formation, consistent with rate-limiting product release. All three data sets can be modeled with a mechanism in which the enzyme-substrate complex reacts with oxygen to form an Fe(IV)═O intermediate with a rate constant of 19 mM(-1) s(-1), the Fe(IV)═O intermediate hydroxylates phenylalanine with a rate constant of 42 s(-1), and rate-limiting product release occurs with a rate constant of 6 s(-1) at 5 °C.

Indexed as

Binding SitesCatalysisChromobacteriumIronKineticsOxygenPhenylalanine HydroxylasePterinsSpectroscopy, MossbauerSubstrate Specificity6-methyltetrahydropterinferryl ironIronOxygenPhenylalanine HydroxylasePterins

Identifiers

PMID21261288
PMCPMC3059337
OpenAlexW2104395874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.